UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR, PLASMINOGEN ACTIVATOR INHIBITOR- 1,EXTRACELLULAR MATRIX METALLOPROTEINASE PROTEIN INDUCER AND CA 15-3ASPOTENTIAL BIOMARKERS FOR DIAGNOSIS - Egyptian Knowledge Bank

9695

UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR, PLASMINOGEN ACTIVATOR INHIBITOR- 1,EXTRACELLULAR MATRIX METALLOPROTEINASE PROTEIN INDUCER AND CA 15-3ASPOTENTIAL BIOMARKERS FOR DIAGNOSIS

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Matrix Metalloproteinase-13 (MMP-13): A proposed Tumor Marker in Breast Carcinoma

Article

OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA

Article

Combining nuclear matrix protein-52, collagen III, and matrix metalloproteinase-1 for more effective breast cancer early detection

Article

Circulating biomarkers of tumor invasiveness for diagnosis and prognosis of cancer metastasis

Article

EVALUATION OF HEPARANASE PROCOAGULANT ACTIVITY AND TISSUE FACTOR PATHWAY INHIBITOR LEVEL IN UTERINE CANCER PATIENTS

Article

Serum NLRP3 and S1P as Potential Diagnostic and Prognostic Biomarkers in Female Metastatic and Non-Metastatic Breast Cancer Patients

Article

Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer

Article

The prognostic value of P53 and CA15.3 tumor markers in breast cancer patient

Article

Soluble urokinase-type plasminogen activator receptor as a diagnostic biomarker for sepsis in intensive care unit patients

Article

EMMPIRRIN (CD147) and matrix metalloproteinase-9 (MMP9) immunohistochemical expression in breast carcinoma: Relationship with clinicopathological paremeters